JS107 in Combination With Toripalimab and Chemotherapy for the Treatment of CLDN18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT07584135 · RECRUITING
Trial details
- NCT number
- NCT07584135
- Sponsor
- NingBo Junyan Hongshi Biosciences Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-28
- Primary completion
- 2029-01-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.